Brown CE - Search Results

1

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.

Brown CE, Badie B, Barish ME, Weng L, Ostberg JR, Chang WC, Naranjo A, Starr R, Wagner J, Wright C, Zhai Y, Bading JR, Ressler JA, Portnow J, D'Apuzzo M, Forman SJ, Jensen MC. Brown CE, et al. Clin Cancer Res. 2015 Sep 15;21(18):4062-72. doi: 10.1158/1078-0432.CCR-15-0428. Epub 2015 Jun 9. Clin Cancer Res. 2015. PMID: 26059190 Free PMC article. Clinical Trial.

2

Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.

Kahlon KS, Brown C, Cooper LJ, Raubitschek A, Forman SJ, Jensen MC. Kahlon KS, et al. Cancer Res. 2004 Dec 15;64(24):9160-6. doi: 10.1158/0008-5472.CAN-04-0454. Cancer Res. 2004. PMID: 15604287

3

Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing.

Brown CE, Wright CL, Naranjo A, Vishwanath RP, Chang WC, Olivares S, Wagner JR, Bruins L, Raubitschek A, Cooper LJ, Jensen MC. Brown CE, et al. J Immunol Methods. 2005 Feb;297(1-2):39-52. doi: 10.1016/j.jim.2004.11.021. Epub 2005 Jan 22. J Immunol Methods. 2005. PMID: 15777929

4

A quantitative high-throughput chemotaxis assay using bioluminescent reporter cells.

Vishwanath RP, Brown CE, Wagner JR, Meechoovet HB, Naranjo A, Wright CL, Olivares S, Qian D, Cooper LJ, Jensen MC. Vishwanath RP, et al. Among authors: brown ce. J Immunol Methods. 2005 Jul;302(1-2):78-89. doi: 10.1016/j.jim.2005.04.021. J Immunol Methods. 2005. PMID: 15987642

5

T-cell genetic modification for re-directed tumor recognition.

Cooper LJ, Kalos M, DiGiusto D, Brown C, Forman SJ, Raubitschek A, Jensen MC. Cooper LJ, et al. Cancer Chemother Biol Response Modif. 2005;22:293-324. doi: 10.1016/s0921-4410(04)22014-2. Cancer Chemother Biol Response Modif. 2005. PMID: 16110618 Review. No abstract available.

6

Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor.

Pameijer CR, Navanjo A, Meechoovet B, Wagner JR, Aguilar B, Wright CL, Chang WC, Brown CE, Jensen MC. Pameijer CR, et al. Among authors: brown ce. Cancer Gene Ther. 2007 Jan;14(1):91-7. doi: 10.1038/sj.cgt.7700993. Epub 2006 Oct 6. Cancer Gene Ther. 2007. PMID: 17024231

7

Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells.

Brown CE, Vishwanath RP, Aguilar B, Starr R, Najbauer J, Aboody KS, Jensen MC. Brown CE, et al. J Immunol. 2007 Sep 1;179(5):3332-41. doi: 10.4049/jimmunol.179.5.3332. J Immunol. 2007. PMID: 17709550

8

Medulloblastomas expressing IL13Ralpha2 are targets for IL13-zetakine+ cytolytic T cells.

Stastny MJ, Brown CE, Ruel C, Jensen MC. Stastny MJ, et al. Among authors: brown ce. J Pediatr Hematol Oncol. 2007 Oct;29(10):669-77. doi: 10.1097/MPH.0b013e3181468c68. J Pediatr Hematol Oncol. 2007. PMID: 17921847

9

Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

Brown CE, Starr R, Martinez C, Aguilar B, D'Apuzzo M, Todorov I, Shih CC, Badie B, Hudecek M, Riddell SR, Jensen MC. Brown CE, et al. Cancer Res. 2009 Dec 1;69(23):8886-93. doi: 10.1158/0008-5472.CAN-09-2687. Epub 2009 Nov 10. Cancer Res. 2009. PMID: 19903840 Free PMC article.

10

Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3.

Yang F, Brown C, Buettner R, Hedvat M, Starr R, Scuto A, Schroeder A, Jensen M, Jove R. Yang F, et al. Mol Cancer Ther. 2010 Apr;9(4):953-62. doi: 10.1158/1535-7163.MCT-09-0947. Epub 2010 Apr 6. Mol Cancer Ther. 2010. PMID: 20371721 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Search Page

Filters